Literature DB >> 10998523

The orphanin FQ/nociceptin gene: structure, tissue distribution of expression and functional implications obtained from knockout mice.

R K Reinscheid1, H Nothacker, O Civelli.   

Abstract

Like other neuropeptides, orphanin FQ/nociceptin (OFQ/N) is encoded by a larger precursor protein. The cDNA for the OFQ/N precursor has been cloned from human, rat, mouse and bovine tissue demonstrating that this peptidergic system serves important functions that have been conserved during evolution. The structural organization of the precursor protein is similar to opioid peptide precursors, supporting the view of a common origin for the opioid systems and the OFQ/N system. In addition to OFQ/N, the precursor may encode two other biologically active peptides. Anatomic studies have revealed high levels of expression of the OFQ/N messenger RNA in brain structures involved in sensory, emotional and cognitive processing. In particular, high levels of OFQ/N mRNA were detected in the limbic system, underlining the stress attenuating activities that have been described as an important function of OFQ/N. Recently, mutant mice have been generated that lack the precursor protein of OFQ/N to further define the physiological functions of the OFQ/N system. The OFQ/N-deficient mice are characterized by an increased sensitivity to stressful stimuli and a lack of habituation to chronic and repeated stress. This review will summarize recent findings on the molecular biology of the OFQ/N precursor and relate it to possible physiological functions of this newly discovered neuropeptide system.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10998523     DOI: 10.1016/s0196-9781(00)00226-6

Source DB:  PubMed          Journal:  Peptides        ISSN: 0196-9781            Impact factor:   3.750


  14 in total

1.  Modification of anxiety-like behaviors by nociceptin/orphanin FQ (N/OFQ) and time-dependent changes in N/OFQ-NOP gene expression following ethanol withdrawal.

Authors:  Harinder Aujla; Rosalia Cannarsa; Patrizia Romualdi; Roberto Ciccocioppo; Rémi Martin-Fardon; Friedbert Weiss
Journal:  Addict Biol       Date:  2012-07-15       Impact factor: 4.280

2.  The dopamine transporter in mesencephalic cultures is refractory to physiological changes in membrane voltage.

Authors:  B M Prasad; S G Amara
Journal:  J Neurosci       Date:  2001-10-01       Impact factor: 6.167

Review 3.  UFP-112 a potent and long-lasting agonist selective for the Nociceptin/Orphanin FQ receptor.

Authors:  Girolamo Calo'; Anna Rizzi; Carlo Cifani; Maria Vittoria Micioni Di Bonaventura; Domenico Regoli; Maurizio Massi; Severo Salvadori; David G Lambert; Remo Guerrini
Journal:  CNS Neurosci Ther       Date:  2010-05-18       Impact factor: 5.243

4.  Biostable aptamers with antagonistic properties to the neuropeptide nociceptin/orphanin FQ.

Authors:  Dirk Faulhammer; Bernd Eschgfäller; Sandra Stark; Petra Burgstaller; Werner Englberger; Jeannette Erfurth; Frank Kleinjung; Johanna Rupp; Sebastian Dan Vulcu; Werner Schröder; Stefan Vonhoff; Hermann Nawrath; Clemens Gillen; Sven Klussmann
Journal:  RNA       Date:  2004-03       Impact factor: 4.942

5.  Antidepressant-like effects of the nociceptin/orphanin FQ receptor antagonist UFP-101: new evidence from rats and mice.

Authors:  E C Gavioli; C W Vaughan; G Marzola; R Guerrini; V A Mitchell; S Zucchini; T C M De Lima; G A Rae; S Salvadori; D Regoli; G Calo'
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2004-05-25       Impact factor: 3.000

6.  Chronic treatment with the selective NOP receptor antagonist [Nphe 1, Arg 14, Lys 15]N/OFQ-NH 2 (UFP-101) reverses the behavioural and biochemical effects of unpredictable chronic mild stress in rats.

Authors:  Giovanni Vitale; Valentina Ruggieri; Monica Filaferro; Claudio Frigeri; Silvia Alboni; Fabio Tascedda; Nicoletta Brunello; Remo Guerrini; Carlo Cifani; Maurizio Massi
Journal:  Psychopharmacology (Berl)       Date:  2009-08-27       Impact factor: 4.530

7.  Developmental changes in the inhibition of cultured rat uterine cell proliferation by opioid peptides.

Authors:  J L Környei; Z Vértes; K A Kovács; P M Göcze; M Vértes
Journal:  Cell Prolif       Date:  2003-06       Impact factor: 6.831

8.  Central injections of nocistatin or its C-terminal hexapeptide exert anxiogenic-like effect on behaviour of mice in the plus-maze test.

Authors:  Elaine C Gavioli; Giles A Rae; Girolamo Calo'; Remo Guerrini; Thereza C M De Lima
Journal:  Br J Pharmacol       Date:  2002-07       Impact factor: 8.739

9.  Effect of orphanin FQ/nociceptin (OFQ/N) and isoflurane on the prolactin secretory response in OFQ/N knockout mice.

Authors:  Kelly L Zullig; Emily Murphree; Rainer K Reinscheid; James Janik; Phyllis Callahan
Journal:  Peptides       Date:  2007-07-14       Impact factor: 3.750

10.  Increased nociceptin/orphanin FQ plasma levels in hepatocellular carcinoma.

Authors:  Ferenc Szalay; Monika B Hantos; Andrea Horvath; Peter L Lakatos; Aniko Folhoffer; Kinga Dunkel; Dalma Hegedus; Kornelia Tekes
Journal:  World J Gastroenterol       Date:  2004-01       Impact factor: 5.742

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.